Diff Profiles › MTBLS226_0001_00000024

G1_Jurkat_Negative_Control_0h_vs_G7_Jurkat_Menaquinone_72h

Jurkat_Negative_Control_0h vs Jurkat_Menaquinone_72h

p-value ≤ 0.05 11 significant 2025-09-26 00:00:00 Study: MTBLS226
68 Total Features
11 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS226_0001_00000024
Linked study
MTBLS226 — Metabolomics identifies the intersection of phosphoethanolamine with menaquinone- triggered apoptosis in an in vitro model of leukemia
Comparison
Jurkat_Negative_Control_0h vs Jurkat_Menaquinone_72h
Group A
Jurkat cells with no treatment at 0 hours. Provides baseline data for comparison with treated Jurkat cells.
Group B
Jurkat cells treated with menaquinone at 72 hours. Evaluates the effect of menaquinone on Jurkat cells at 72 hours.
Total features tested
68
Significant features
11
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
ZWLPBLYKEWSWPD-UHFFFAOYSA-N 2-toluic acid up 584.1 0.00184
GRFNBEZIAWKNCO-UHFFFAOYSA-N <em>m</em>-hydroxypyridine down 0.000228 0.0117
SUHOOTKUPISOBE-UHFFFAOYSA-N colamine phosphate down 0.2425 2.06e-05
UCMIRNVEIXFBKS-UHFFFAOYSA-N 3-ammoniopropanoate down 0.3563 0.00142
VVIUBCNYACGLLV-UHFFFAOYSA-N 2-mmonioethane-1-sulfinate down 0.3874 0.0013
PMMYEEVYMWASQN-DMTCNVIQSA-N hydroxyproline zwitterion down 0.447 0.00409
NWVVVBRKAWDGAB-UHFFFAOYSA-N 1-Hydroxy-4-methoxybenzene up 2.185 0.0211
FBZANXDWQAVSTQ-UHFFFAOYSA-N dodecamethylpentasiloxane down 0.5505 0.0067
MVULGCSHGFLUBH-UHFFFAOYSA-N 1,1'-{3-[(phenylsulfinyl)methyl]cyclopropane-1,2-diyl}dibenzene up 1.527 0.00349
HEBKCHPVOIAQTA-SCDXWVJYSA-N Xylit down 0.5313 0.0303